Detalhe da pesquisa
1.
Spirooxadiazoline-oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells.
Arch Pharm (Weinheim)
; : e2400029, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627294
2.
QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.
J Chem Inf Model
; 56(7): 1357-72, 2016 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27253773
3.
Synthesis, cytotoxicity and mechanistic evaluation of 4-oxoquinoline-3-carboxamide derivatives: finding new potential anticancer drugs.
Molecules
; 19(5): 6651-70, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24858098
4.
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
Front Immunol
; 12: 642383, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135888
5.
Filtering promiscuous compounds in early drug discovery: is it a good idea?
Drug Discov Today
; 21(6): 868-72, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26880580
6.
Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.
J Med Chem
; 59(15): 7075-88, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27396732
7.
Does active Crohn's disease have decreased intestinal antioxidant capacity?
J Crohns Colitis
; 7(9): e358-66, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23523266